•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A08502 Summary:

BILL NOA08502
 
SAME ASSAME AS S08040
 
SPONSORHunter
 
COSPNSRGunther, Santabarbara
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L; amd §5, Chap of 2023 (as proposed in S.1196-A & A.1673-A)
 
Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.
Go to top